List of Excipients in API oxcarbazepine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing oxcarbazepine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | CELLULOSE, MICROCRYSTALLINE | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | CROSPOVIDONE | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | FERRIC OXIDE YELLOW | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | HYPROMELLOSES | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | MAGNESIUM STEARATE | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | POLYETHYLENE GLYCOL | |
| Novartis Pharmaceuticals Corporation | TRILEPTAL | oxcarbazepine | 0078-0456 | SILICON DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing oxcarbazepine
Detailed excipient profiles for oxcarbazepine
Excipient focus: ALCOHOL
oxcarbazepine drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
oxcarbazepine drug variants containing ALUMINUM OXIDE
oxcarbazepine drug variants not containing ALUMINUM OXIDE
Excipient focus: ASCORBIC ACID
oxcarbazepine drug variants containing ASCORBIC ACID
oxcarbazepine drug variants not containing ASCORBIC ACID
Excipient focus: CARBOXYMETHYLCELLULOSE
oxcarbazepine drug variants containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing CARBOXYMETHYLCELLULOSE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
oxcarbazepine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
oxcarbazepine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Excipient focus: CELLULOSE, MICROCRYSTALLINE
oxcarbazepine drug variants containing CELLULOSE, MICROCRYSTALLINE
oxcarbazepine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE K25-31
oxcarbazepine drug variants containing COPOVIDONE K25-31
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSCARMELLOSE SODIUM
oxcarbazepine drug variants containing CROSCARMELLOSE SODIUM
oxcarbazepine drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
oxcarbazepine drug variants containing CROSPOVIDONE
oxcarbazepine drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
oxcarbazepine drug variants containing FD&C BLUE NO. 2
oxcarbazepine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 5
oxcarbazepine drug variants containing FD&C YELLOW NO. 5
oxcarbazepine drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
oxcarbazepine drug variants containing FD&C YELLOW NO. 6
oxcarbazepine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
oxcarbazepine drug variants containing FERRIC OXIDE RED
oxcarbazepine drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
oxcarbazepine drug variants containing FERRIC OXIDE YELLOW
oxcarbazepine drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
oxcarbazepine drug variants containing FERROSOFERRIC OXIDE
oxcarbazepine drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROCHLORIC ACID
oxcarbazepine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| REMEDYREPACK INC | oxcarbazepine | 70518-2946 |
| Bryant Ranch Prepack | oxcarbazepine | 72162-2088 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
oxcarbazepine drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
oxcarbazepine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| Advagen Pharma Limited | oxcarbazepine | 72888-087 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
oxcarbazepine drug variants containing HYPROMELLOSE
oxcarbazepine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
oxcarbazepine drug variants containing HYPROMELLOSE 2910
oxcarbazepine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
oxcarbazepine drug variants containing HYPROMELLOSES
oxcarbazepine drug variants not containing HYPROMELLOSES
Excipient focus: LECITHIN, SOYBEAN
oxcarbazepine drug variants containing LECITHIN, SOYBEAN
oxcarbazepine drug variants not containing LECITHIN, SOYBEAN
Excipient focus: LEMON
oxcarbazepine drug variants containing LEMON
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| NorthStar RxLLC | oxcarbazepine | 72603-252 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing LEMON
Excipient focus: MAGNESIUM STEARATE
oxcarbazepine drug variants containing MAGNESIUM STEARATE
oxcarbazepine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALIC ACID
oxcarbazepine drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| REMEDYREPACK INC | oxcarbazepine | 70518-2946 |
| Bryant Ranch Prepack | oxcarbazepine | 72162-2088 |
| Advagen Pharma Ltd | oxcarbazepine | 72888-074 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing MALIC ACID
Excipient focus: MEGLUMINE
oxcarbazepine drug variants containing MEGLUMINE
oxcarbazepine drug variants not containing MEGLUMINE
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
oxcarbazepine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHYLCELLULOSE
oxcarbazepine drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Limited | oxcarbazepine | 72888-087 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHYLCELLULOSE
Excipient focus: METHYLPARABEN
oxcarbazepine drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing METHYLPARABEN
Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION
oxcarbazepine drug variants containing NONCRYSTALLIZING SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| NorthStar RxLLC | oxcarbazepine | 72603-252 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing NONCRYSTALLIZING SORBITOL SOLUTION
Excipient focus: PEG-8 STEARATE
oxcarbazepine drug variants containing PEG-8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Akorn | oxcarbazepine | 50383-312 |
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| Glasshouse Pharmaceuticals Limited Canada | oxcarbazepine | 71428-007 |
| NorthStar RxLLC | oxcarbazepine | 72603-252 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PEG-8 STEARATE
Excipient focus: PLUM
oxcarbazepine drug variants containing PLUM
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PLUM
Excipient focus: POLYETHYLENE GLYCOL
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 2000
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 2000
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 2000
Excipient focus: POLYETHYLENE GLYCOL 3350
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 3350
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
oxcarbazepine drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
oxcarbazepine drug variants containing POLYETHYLENE GLYCOLS
oxcarbazepine drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYOXYL 8 STEARATE
oxcarbazepine drug variants containing POLYOXYL 8 STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| Bionpharma Inc | oxcarbazepine | 69452-125 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POLYOXYL 8 STEARATE
Excipient focus: POLYSORBATE 80
oxcarbazepine drug variants containing POLYSORBATE 80
oxcarbazepine drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
oxcarbazepine drug variants containing POLYVINYL ALCOHOL
oxcarbazepine drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
oxcarbazepine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
oxcarbazepine drug variants containing POVIDONE K30
oxcarbazepine drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
oxcarbazepine drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing POVIDONES
Excipient focus: PROPYLENE GLYCOL
oxcarbazepine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLPARABEN
oxcarbazepine drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing PROPYLPARABEN
Excipient focus: SACCHARIN SODIUM
oxcarbazepine drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SACCHARIN SODIUM
Excipient focus: SACCHARIN SODIUM ANHYDROUS
oxcarbazepine drug variants containing SACCHARIN SODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SACCHARIN SODIUM ANHYDROUS
Excipient focus: SILICON DIOXIDE
oxcarbazepine drug variants containing SILICON DIOXIDE
oxcarbazepine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
oxcarbazepine drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| REMEDYREPACK INC | oxcarbazepine | 70518-2946 |
| Bryant Ranch Prepack | oxcarbazepine | 72162-2088 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM HYDROXIDE
oxcarbazepine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| REMEDYREPACK INC | oxcarbazepine | 70518-2946 |
| Bryant Ranch Prepack | oxcarbazepine | 72162-2088 |
| Advagen Pharma Ltd | oxcarbazepine | 72888-074 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
oxcarbazepine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Supernus Pharmaceuticals Inc | oxcarbazepine | 17772-121 |
| Ajanta Pharma USA Inc | oxcarbazepine | 27241-237 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
oxcarbazepine drug variants containing SODIUM STEARYL FUMARATE
oxcarbazepine drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SORBIC ACID
oxcarbazepine drug variants containing SORBIC ACID
oxcarbazepine drug variants not containing SORBIC ACID
Excipient focus: SORBITOL
oxcarbazepine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| Ranbaxy Pharmaceuticals Inc | oxcarbazepine | 63304-653 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| Bionpharma Inc | oxcarbazepine | 69452-125 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SORBITOL
Excipient focus: SORBITOL SOLUTION
oxcarbazepine drug variants containing SORBITOL SOLUTION
| Company | Ingredient | NDC |
|---|---|---|
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SORBITOL SOLUTION
Excipient focus: STARCH, CORN
oxcarbazepine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| AvPAK | oxcarbazepine | 50268-649 |
| Amneal Pharmaceuticals LLC | oxcarbazepine | 65162-649 |
| Precision Dose Inc | oxcarbazepine | 68094-123 |
| REMEDYREPACK INC | oxcarbazepine | 70518-2946 |
| Bryant Ranch Prepack | oxcarbazepine | 72162-2088 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
oxcarbazepine drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| >Company | >Ingredient | >NDC |
oxcarbazepine drug variants not containing SUCROSE
Excipient focus: TALC
oxcarbazepine drug variants containing TALC
oxcarbazepine drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
oxcarbazepine drug variants containing TITANIUM DIOXIDE
oxcarbazepine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | oxcarbazepine | 0054-0199 |
| Sandoz Inc | oxcarbazepine | 0781-6270 |
| Camber Pharmaceuticals Inc | oxcarbazepine | 31722-687 |
| EPIC PHARMA LLC | oxcarbazepine | 42806-600 |
| Medley Pharmaceuticals Limited | oxcarbazepine | 42934-401 |
| AvPAK | oxcarbazepine | 50268-649 |
| Akorn | oxcarbazepine | 50383-312 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
oxcarbazepine drug variants containing WATER
oxcarbazepine drug variants not containing WATER
Excipient focus: XANTHAN GUM
oxcarbazepine drug variants containing XANTHAN GUM
oxcarbazepine drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
